Real-World Dose Titration Patterns Across Age Groups in Patients Treated With Delayed-Release/Extended-Release Methylphenidate in the United States

This publication has 15 references indexed in Scilit:

• ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment
  Journal of Clinical Child & Adolescent Psychology, 2024
• Attention-deficit hyperactivity disorder
  The Lancet, 2020
• A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings
  Journal of Child and Adolescent Psychopharmacology, 2020
• Treatment strategies for ADHD: an evidence-based guide to select optimal treatment
  Molecular Psychiatry, 2018
• Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder
  Journal of Child and Adolescent Psychopharmacology, 2017
• Meta-analysis of quality of life in children and adolescents with ADHD: By both parent proxy-report and child self-report using PedsQL™
  Research in Developmental Disabilities, 2016
• Attention deficit hyperactivity disorder
  The Lancet, 2016
• Attention-deficit/hyperactivity disorder
  Nature Reviews Disease Primers, 2015
• The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
  European Child & Adolescent Psychiatry, 2009
• Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery
  Journal of Clinical Epidemiology, 2006